LIS
RDY icon

Legacy Investment Solutions’s Dr. Reddy's Laboratories RDY Stock Holding History

Legacy Investment Solutions’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$226 Buy
+15
New +$214 ﹤0.01% 700
2024
Q4 		$209 Sell
15
-60
-80% -$901 ﹤0.01% 715
2024
Q3 		$219 Buy
+75
New +$1.21K ﹤0.01% 664

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legacy Investment Solutions's RDY Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2025: 15 shares worth $226. The stake represents ﹤0.01% of the portfolio and ranks #700 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in RDY as recently as Q4 2024.

Legacy Investment Solutions first reported a position in RDY in Q3 2024 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Legacy Investment Solutions held 15 shares of Dr. Reddy's Laboratories worth $226 as of Q2 2025.
  • Dr. Reddy's Laboratories was a new Legacy Investment Solutions position in Q2 2025.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #700 holding.
  • Legacy Investment Solutions first reported a position in Dr. Reddy's Laboratories in Q3 2024 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.